No results for ‘’
Caplin Point Laboratories Ltd
NSE: CAPLIPOINT BSE: 524742
₹2582.90
(1.47%)
Thu, 16 Jul 2026, 04:36 am
Market Cap (in Cr)19918.1
PE Ratio30.71
Dividend0.28
Health Technology
Pharmaceuticals: Major
24.5KCaplin Point Laboratories Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 396355 | 1899.6 | 26 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 396355 | 1901.28 | 26 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 444478 | 1763.58 | 19 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 444478 | 1761.72 | 19 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 381306 | 908.54 | 09 Sept 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 381306 | 908.19 | 09 Sept 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 414981 | 957.37 | 27 Jul 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 414981 | 957.62 | 27 Jul 2021 |
| XTX MARKETS LLP | bulk | Buy | 464203 | 908.91 | 26 Jul 2021 |
| XTX MARKETS LLP | bulk | Sell | 460816 | 910.58 | 26 Jul 2021 |
Showing 1–10 of 10
Rows per page: